These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11890469)

  • 21. Maximizing the value of genomics in the drug discovery and development process.
    Spence P
    Prog Drug Res; 2003; 60():159-70. PubMed ID: 12790342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of genomics to toxicology research.
    Thomas RS; Rank DR; Penn SG; Zastrow GM; Hayes KR; Hu T; Pande K; Lewis M; Jovanovich SB; Bradfield CA
    Environ Health Perspect; 2002 Dec; 110 Suppl 6(Suppl 6):919-23. PubMed ID: 12634120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxicogenomics: an emerging discipline.
    Schmidt CW
    Environ Health Perspect; 2002 Dec; 110(12):A750-5. PubMed ID: 12460812
    [No Abstract]   [Full Text] [Related]  

  • 24. Expression profiling of drug response--from genes to pathways.
    Herwig R; Lehrach H
    Dialogues Clin Neurosci; 2006; 8(3):283-93. PubMed ID: 17117610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?
    Lühe A; Suter L; Ruepp S; Singer T; Weiser T; Albertini S
    Mutat Res; 2005 Aug; 575(1-2):102-15. PubMed ID: 15924886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding mechanisms of toxicity: insights from drug discovery research.
    Houck KA; Kavlock RJ
    Toxicol Appl Pharmacol; 2008 Mar; 227(2):163-78. PubMed ID: 18063003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of traditional end points and gene dysregulation to understand mechanisms of toxicity: toxicogenomics in mechanistic toxicology.
    Buck WR; Waring JF; Blomme EA
    Methods Mol Biol; 2008; 460():23-44. PubMed ID: 18449481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the toxicologic pathologist in the biopharmaceutical industry.
    van Tongeren S; Fagerland JA; Conner MW; Diegel K; Donnelly K; Grubor B; Lopez-Martinez A; Bolliger AP; Sharma A; Tannehill-Gregg S; Turner PV; Wancket LM
    Int J Toxicol; 2011 Oct; 30(5):568-82. PubMed ID: 21878555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals.
    Stierum R; Heijne W; Kienhuis A; van Ommen B; Groten J
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):179-88. PubMed ID: 16139318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base.
    Waters M; Boorman G; Bushel P; Cunningham M; Irwin R; Merrick A; Olden K; Paules R; Selkirk J; Stasiewicz S; Weis B; Van Houten B; Walker N; Tennant R
    EHP Toxicogenomics; 2003 Jan; 111(1T):15-28. PubMed ID: 12735106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicologic pathology in the new millennium.
    Ettlin RA; Leininger JR
    Toxicol Pathol; 2002; 30(1):160-3. PubMed ID: 11890471
    [No Abstract]   [Full Text] [Related]  

  • 32. Transcriptomics in predictive toxicology.
    Storck T; von Brevern MC; Behrens CK; Scheel J; Bach A
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):90-7. PubMed ID: 11865677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxicologic pathology in the 21st century.
    Ettlin RA
    Toxicol Pathol; 2013 Jul; 41(5):689-708. PubMed ID: 23143188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomics and systems biology--how relevant are the developments to veterinary pharmacology, toxicology and therapeutics?
    Witkamp RF
    J Vet Pharmacol Ther; 2005 Jun; 28(3):235-45. PubMed ID: 15953196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery in toxicology: mediation by gene expression array technology.
    Hamadeh HK; Bushel P; Paules R; Afshari CA
    J Biochem Mol Toxicol; 2001; 15(5):231-42. PubMed ID: 11835620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pathologist and toxicologist in pharmaceutical product discovery.
    Alden CL; Sagartz JE; Smith PF; Wilson AG; Bunch RT; Morris DL
    Toxicol Pathol; 1999; 27(1):104-6. PubMed ID: 10367682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action.
    Ganter B; Tugendreich S; Pearson CI; Ayanoglu E; Baumhueter S; Bostian KA; Brady L; Browne LJ; Calvin JT; Day GJ; Breckenridge N; Dunlea S; Eynon BP; Furness LM; Ferng J; Fielden MR; Fujimoto SY; Gong L; Hu C; Idury R; Judo MS; Kolaja KL; Lee MD; McSorley C; Minor JM; Nair RV; Natsoulis G; Nguyen P; Nicholson SM; Pham H; Roter AH; Sun D; Tan S; Thode S; Tolley AM; Vladimirova A; Yang J; Zhou Z; Jarnagin K
    J Biotechnol; 2005 Sep; 119(3):219-44. PubMed ID: 16005536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory forum opinion piece: the role of the toxicologic pathologist in the postgenomic era: challenges and opportunities.
    Maronpot RR
    Toxicol Pathol; 2012 Oct; 40(7):1082-6. PubMed ID: 22585943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomics in environmental health research--opportunities and challenges.
    Olden K
    Toxicology; 2004 May; 198(1-3):19-24. PubMed ID: 15138025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of genomics in preclinical drug safety evaluation.
    Lord PG; Nie A; McMillian M
    Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):537-46. PubMed ID: 16700814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.